Who is sponsoring NCT05037344?

NCT05037344 is sponsored by University Hospital Tuebingen.

What drugs are being tested in NCT05037344?

Interventions in NCT05037344: Cognitive-behavioral psychotherapy.

What condition does NCT05037344 study?

NCT05037344 studies Psychotherapy Intervention Evaluation.

Is NCT05037344 still recruiting?

NCT05037344 is currently completed. Last updated 8 July 2022.

Last reviewed 2022-07-08 · How we verify

NCT05037344

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

iCBT for Children and Adolescents With Obsessive-compulsive Disorder II

Completed NA Last updated 8 July 2022

What this trial tests

NA trial testing Cognitive-behavioral psychotherapy in Psychotherapy Intervention Evaluation in 60 participants. Completed in 30 April 2022.

Timeline

4 March 2019

Primary endpoint
30 April 2022

30 April 2022

Quick facts

Lead sponsor	University Hospital Tuebingen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	4 March 2019
Primary completion	30 April 2022
Estimated completion	30 April 2022
Sites	1 location across Germany

Drugs / interventions tested

Cognitive-behavioral psychotherapy

Conditions studied

Psychotherapy Intervention Evaluation — all drugs for Psychotherapy Intervention Evaluation →

Sponsor

University Hospital Tuebingen

Who can join

Adults 6 to 18, any sex, with Psychotherapy Intervention Evaluation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Internet-based psychotherapy for children and adolescents with obsessive-compulsive symptoms and an age of 6 to 18 years. Sessions are verified with teleconferencing with an psychotherapist, children and their parents. The psychotherapy is supported by an App and a wristband to obtain psychophysiological data. The investigators have already successfully performed a feasibility study.The goal of the current proposal is to develop an internet and smart phone delivered CBT (iCBT) for the treatment of pediatric OCD on the bases of the feasibility study. Internal testing on iCBT therapy package and developmental workchanges has been done. The investigators are now evaluating effectiveness in an RCT.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Internet-based cognitive behavioral therapy in children and adolescents with obsessive-compulsive disorder: A randomized controlled trial.
Hollmann K, Hohnecker CS, Haigis A, Alt AK, et al · · 2022 · cited 17× · PMID 36329915 · DOI 10.3389/fpsyt.2022.989550
Internet-based psychotherapy in children with obsessive-compulsive disorder (OCD): protocol of a randomized controlled trial.
Conzelmann A, Hollmann K, Haigis A, Lautenbacher H, et al · · 2022 · cited 7× · PMID 35189937 · DOI 10.1186/s13063-022-06062-w

Verify or expand the search:

Other University Hospital Tuebingen trials

Trials by the same sponsor.

NCT07378670 — DEfeating PEnile CAncer-2 · NA · recruiting
NCT07276503 — Verification of a New Predictive Delirium Score in Adults With Elective Cardiac Valve or Bypass Surgery With Perioperati · not yet recruiting
NCT07411365 — Dual-task Cognitive-motor Telerehabilitation in Persons With PD-MCI · NA · not yet recruiting
NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
NCT07378891 — Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI) · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05037344 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Tuebingen
Last refreshed: 8 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05037344.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing